rs199996504
Variant summary
Our verdict is Benign. Variant got -15 ACMG points: 1P and 16B. PP2BP4_StrongBP6_Very_StrongBS2
The NM_182961.4(SYNE1):c.15451G>A(p.Val5151Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000502 in 1,614,166 control chromosomes in the GnomAD database, including 12 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_182961.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -15 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SYNE1 | NM_182961.4 | c.15451G>A | p.Val5151Met | missense_variant | 81/146 | ENST00000367255.10 | NP_892006.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SYNE1 | ENST00000367255.10 | c.15451G>A | p.Val5151Met | missense_variant | 81/146 | 1 | NM_182961.4 | ENSP00000356224 | P1 | |
SYNE1 | ENST00000423061.6 | c.15238G>A | p.Val5080Met | missense_variant | 80/146 | 1 | ENSP00000396024 | |||
SYNE1 | ENST00000490135.6 | n.2797G>A | non_coding_transcript_exon_variant | 5/11 | 1 |
Frequencies
GnomAD3 genomes AF: 0.000191 AC: 29AN: 152168Hom.: 1 Cov.: 33
GnomAD3 exomes AF: 0.000998 AC: 251AN: 251404Hom.: 5 AF XY: 0.00138 AC XY: 188AN XY: 135888
GnomAD4 exome AF: 0.000534 AC: 781AN: 1461882Hom.: 11 Cov.: 32 AF XY: 0.000770 AC XY: 560AN XY: 727244
GnomAD4 genome AF: 0.000190 AC: 29AN: 152284Hom.: 1 Cov.: 33 AF XY: 0.000269 AC XY: 20AN XY: 74472
ClinVar
Submissions by phenotype
not specified Benign:2
Likely benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Apr 10, 2017 | - - |
Benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | Mar 20, 2018 | - - |
Autosomal recessive ataxia, Beauce type;C2751807:Emery-Dreifuss muscular dystrophy 4, autosomal dominant Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 21, 2024 | - - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jun 01, 2024 | SYNE1: BP4, BS2 - |
SYNE1-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Dec 10, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at